Leadership

Alexander G.G. Turpie, MD, FRCP, FACP, FACC, FRCPC

turpie

Emeritus Professor of Medicine McMaster University

Internist Hamilton Health Sciences, Hamilton, Ontario, Canada.

Alexander G.G. Turpie is Emeritus Professor of medicine at McMaster University, and an internist on the staff of Hamilton Health Sciences, Hamilton, Ontario, Canada. Dr Turpie received his medical education from the University of Glasgow, Scotland. After completing a residency at the Royal Infirmary in Glasgow, as well as a residency and clinical research fellowship at Stobhill General Hospital, also in Glasgow, he served as a clinic lecturer for the University of East Africa Medical School in Nairobi, Kenya. He was later elected a fellow of the Royal College of Physicians and Surgeons of Canada, of Glasgow and of London. Dr Turpie is also a fellow of the American College of Physicians and the American College of Cardiology, and has served on numerous professional and university-related committees throughout his career.

Dr Turpie is a prolific author, with over 700 published articles, abstracts, book chapters, and books. He is also a frequent lecturer at professional meetings worldwide. He is a reviewer for many journals, including Annals of Internal Medicine, Circulation, LANCET and The New England Journal of Medicine, as well as serving on the editorial board of Vascular Medicine Review and HeartDrug. He was also an external examiner in medicine for the MD and MBBS degree programmes of the University of the West Indies, and MB ChB programmes at the Chinese University of Hong Kong. Dr Turpie’s research interests include new antithrombotic drugs in the management of venous and arterial thrombosis and anticoagulant therapy in patients with prosthetic heart valves.

Contact:
Hamilton Health Sciences, General Hospital
237 Barton Street East
Hamilton, Ontario, Canada
L8L 2X2
Phone: (905) 528-9946
Fax: (905) 521-1551
Email: turpiea@mcmaster.ca

Publications

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.


Bassand JP, Accetta G, Camm AJ, Cools F, Fitzmaurice DA, Fox KA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Mantovani LG, Misselwitz F, Ten Cate H, Turpie AG, Verheugt FW, Kakkar AK; GARFIELD-AF Investigators.

Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation.


Kittelson JM, Steg PG, Halperin JL, Goldenberg NA, Schulman S, Spyropoulos AC, Kessler CM, Turpie AG, Cutler NR, Hiatt WR; Antithrombotic Trials Leadership and Steering (ATLAS) Group.

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.


Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators.

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: Co-medication interactions.


Kreutz R, Haas S, Holberg G, Lassen MR, Mantovani LG, Schmidt A, Turpie AG.

For additional research publications please visit: https://www.researchgate.net/profile/Alexander_Turpie